Back

A Longitudinal Study of Executive Function in Daily Life in Male Fragile X Premutation Carriers and Association with FXTAS Conversion

Hessl, D.; Mandujano, K.; Ferrer, E.; Espinal, G.; Famula, J.; Schneider, A.; Hagerman, R.; Tassone, F.; Rivera, S.

2023-09-02 psychiatry and clinical psychology
10.1101/2023.08.31.23294855 medRxiv
Show abstract

BackgroundMen with fragile X-associated tremor/ataxia syndrome (FXTAS) often develop executive dysfunction, characterized by disinhibition, frontal dyscontrol of movement, and working memory and attention changes. Although cross-sectional studies have suggested that earlier executive function changes may precede FXTAS, the lack of longitudinal studies have made it difficult to address this hypothesis. MethodsThis study included 66 FMR1 premutation carriers (PC) ranging from 40-78 years (Mean=59.5) and 31 well-matched healthy controls (HC) ages 40-75 (Mean 57.7) at baseline. Eighty-four participants returned for 2-5 follow up visits over a duration of 1 to 9 years (Mean=4.6); 28 of the PC developed FXTAS. The Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) was completed by participants and their spouses/partners at each visit. ResultsLongitudinal mixed model regression analyses showed a greater decline with age in PC compared to HC on the Metacognition Index (MI; self-initiation, working memory, organization, task monitoring). Conversion to FXTAS was associated with worsening MI and Behavioral Regulation Index (BRI; inhibition, flexibility, emotion modulation). For spouse/partner report, FXTAS conversion was associated with worsening MI. Finally, BRIEF-A executive function problems at baseline significantly predicted later development of FXTAS. ConclusionsThese findings suggest that executive function changes represent a prodrome of the later movement disorder.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Journal of Neurology, Neurosurgery & Psychiatry
29 papers in training set
Top 0.1%
12.5%
2
Neurobiology of Disease
134 papers in training set
Top 0.5%
9.2%
3
Movement Disorders
62 papers in training set
Top 0.3%
6.9%
4
Brain Communications
147 papers in training set
Top 0.4%
4.9%
5
NeuroImage: Clinical
132 papers in training set
Top 0.9%
4.9%
6
Neurology Genetics
14 papers in training set
Top 0.1%
4.9%
7
Frontiers in Neurology
91 papers in training set
Top 1%
4.2%
8
PLOS ONE
4510 papers in training set
Top 35%
4.2%
50% of probability mass above
9
Neurology
44 papers in training set
Top 0.5%
2.9%
10
Psychiatry Research
35 papers in training set
Top 0.6%
2.8%
11
Journal of Autism and Developmental Disorders
12 papers in training set
Top 0.1%
2.1%
12
Scientific Reports
3102 papers in training set
Top 55%
1.8%
13
Journal of Neurodevelopmental Disorders
15 papers in training set
Top 0.2%
1.7%
14
Frontiers in Aging Neuroscience
67 papers in training set
Top 2%
1.7%
15
Journal of Neurology
26 papers in training set
Top 0.7%
1.7%
16
Annals of Neurology
57 papers in training set
Top 1%
1.5%
17
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 1.0%
1.5%
18
Frontiers in Psychiatry
83 papers in training set
Top 2%
1.2%
19
Human Molecular Genetics
130 papers in training set
Top 2%
1.2%
20
Acta Neuropsychiatrica
12 papers in training set
Top 0.6%
1.2%
21
Psychiatry Research: Neuroimaging
16 papers in training set
Top 0.2%
1.0%
22
Autism Research
32 papers in training set
Top 0.4%
0.8%
23
The British Journal of Psychiatry
21 papers in training set
Top 0.9%
0.8%
24
Acta Psychiatrica Scandinavica
10 papers in training set
Top 0.4%
0.8%
25
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
22 papers in training set
Top 0.4%
0.8%
26
European Psychiatry
10 papers in training set
Top 0.7%
0.7%
27
Molecular Autism
29 papers in training set
Top 0.4%
0.7%
28
Journal of Psychiatric Research
28 papers in training set
Top 0.8%
0.7%
29
Multiple Sclerosis and Related Disorders
15 papers in training set
Top 0.2%
0.6%
30
Journal of Alzheimer's Disease
43 papers in training set
Top 1%
0.6%